Charles River Analyst Price Targets - Benzinga

Charles River Laboratories International Inc

CRLNYSE

Trade with Public

Trade with Public

$359.31

0.470.13%

Dern. MÀJ: Oct 27, 5:53 PM

Aperçu Actualités Prévisions de résultats ÉvénementsObjectifs de coursDonnées financières Sentiment Actionnariat Comparer Options Rapport sur les stocks

© 2026 Benzinga | All Rights Reserved

Charles River Analyst Price Targets - Benzinga

Charles River Analyst Price Targets

Wall Street analyst price targets and consensus rating for Charles River (CRL).

Price Target Range — 12 Quarters

Analyst Consensus — 18 Analysts

13Buy

5Hold

Consensus RatingBuy# Analysts18Avg. Consensus PT$276Upside to Avg. PT-23.2%

Rating Trend — Last 9 Months

Recent Analyst Actions

Voir toutes les évaluations →

Date	Firm	Analyst	Action	Rating Change	Price Target
Oct 13, 2026	Morgan Stanley	Ricky Goldwasser	PT Raise	Overweight	$300→$340
Sep 30, 2026	UBS	Kevin Caliendo	Reinstates	Buy	$357
Sep 28, 2026	Jefferies	David Windley	PT Raise	Buy	$305→$340
Sep 25, 2026	Deutsche Bank	Justin Bowers	PT Raise	Buy	$300→$320
Sep 25, 2026	TD Cowen	Charles Rhyee	PT Raise	Buy	$300→$325
Sep 25, 2026	Evercore ISI Group	Ross Muken	PT Raise	Outperform	$320→$330
Sep 25, 2026	RBC Capital	Ryan Halsted	PT Raise	Outperform	$282→$322
Sep 25, 2026	Barclays	Luke Sergott	PT Raise	Overweight	$300→$330
Sep 25, 2026	Mizuho	Ann Hynes	PT Raise	Neutral	$264→$295
Sep 25, 2026	Baird	Eric Coldwell	PT Raise	Outperform	$291→$334
Sep 11, 2026	Evercore ISI Group	Ross Muken	PT Raise	Outperform	$300→$320
Aug 10, 2026	TD Cowen	Charles Rhyee	PT Raise	Buy	$235→$300
Aug 7, 2026	Morgan Stanley	Ricky Goldwasser	PT Raise	Overweight	$260→$300
Aug 6, 2026	RBC Capital	Ryan Halsted	PT Raise	Outperform	$215→$282
Aug 6, 2026	Evercore ISI Group	Ross Muken	PT Raise	Outperform	$260→$300
Aug 6, 2026	JP Morgan	Casey Woodring	Upgrade	Neutral→Overweight	$180→$310
Jul 20, 2026	CLSA	Michael Luo	Downgrade	Outperform→Hold	$219
Jul 13, 2026	Mizuho	Ann Hynes	PT Raise	Neutral	$192→$230
Jul 9, 2026	Morgan Stanley	Ricky Goldwasser	PT Raise	Overweight	$220→$260
Jun 17, 2026	Morgan Stanley	Ricky Goldwasser	Upgrade	Equal-Weight→Overweight	$185→$220

Analyst Ratings News

PRO
Morgan Stanley Maintains Overweight on Charles River, Raises Price Target to $340

Morgan Stanley analyst Ricky Goldwasser maintains Charles River (NYSE:CRL) with a Overweight and raises the price target from $300 to $340.

Benzinga Newsdesk

PRO
UBS Reinstates Buy on Charles River, Announces $357 Price Target

UBS analyst Kevin Caliendo reinstates Charles River (NYSE:CRL) with a Buy and announces $357 price target.

Benzinga Newsdesk

PRO
Jefferies Maintains Buy on Charles River, Raises Price Target to $340

Jefferies analyst David Windley maintains Charles River (NYSE:CRL) with a Buy and raises the price target from $305 to $340.

Benzinga Newsdesk

PRO
Deutsche Bank Maintains Buy on Charles River, Raises Price Target to $320

Deutsche Bank analyst Justin Bowers maintains Charles River (NYSE:CRL) with a Buy and raises the price target from $300 to $320.

Benzinga Newsdesk

PRO
TD Cowen Maintains Buy on Charles River, Raises Price Target to $325

TD Cowen analyst Charles Rhyee maintains Charles River (NYSE:CRL) with a Buy and raises the price target from $300 to $325.

Benzinga Newsdesk

PRO
Evercore ISI Group Maintains Outperform on Charles River, Raises Price Target to $330

Evercore ISI Group analyst Ross Muken maintains Charles River (NYSE:CRL) with a Outperform and raises the price target from $320 to $330.

Benzinga Newsdesk